Optimizing acute ischemic stroke outcome prediction by integrating radiomics features of DSC-PWI and perfusion parameter maps

通过整合DSC-PWI和灌注参数图的放射组学特征来优化急性缺血性卒中预后预测

阅读:2

Abstract

INTRODUCTION: Accurate prediction of the prognostic outcomes for patients with ischemic stroke can contribute to personalized treatment decisions and improve life-saving outcomes. This study focuses on the performance of critical moments DSC-PWI in the prognostic prediction of acute ischemic stroke (AIS). It aims to integrate this with perfusion parameters to enhance prediction accuracy. METHODS: Firstly, The radiomics technique employed to extract DSC-PWI features of critical moments and perfusion parameter features. Following this, a T-test and Lasso algorithm was used to select features associated with the prognosis. Subsequently, machine learning techniques were applied to predict the predictive outcomes of AIS patients. RESULTS: The experimental results showed that DSC-PWI sequences at three critical time points-the first moment after contrast injection, the moment of minimum mean time intensity, and the last moment, collectively referred to as 3PWI, had better prognostic prediction than a single perfusion parameter, achieving an optimal model AUC of 0.863. The performance improved by 23.9, 19.6, 6, and 24% compared with CBV, CBF, MTT, and Tmax parameters. The best prognostic prediction for AIS was obtained by integrating the radiomic features from both 3PWI and perfusion parameters, resulting in the highest AUC of 0.915. DISCUSSION: Integrating the radiomics features of DSC-PWI sequences of three critical scan time points with those from perfusion parameters can further improve the accuracy of prognostic prediction for AIS patients. This approach may provide new insights into the prognostic evaluation of AIS and provide clinicians with valuable support in making treatment decisions.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。